OR WAIT null SECS
CRO Aptus Clinical has been appointed as a supplier for clinical services by the Cell and Gene Therapy Catapult (CGTC). As an early-phase CRO, its role is to support development and delivery of advanced therapy studies in the UK and Europe. Through this partnership, Aptus Clinical will primarily provide dedicated site set-up and monitoring of investigational sites for the CGTC’s collaborators.
Read the full release here.